SCHEMBL21864955

SCHEMBL21864955

CC(C)(C)OC(=O)NC/C(=C\F)COc1ccc2nc(NC(=O)C(C)(C)C)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 4/20 0.41
▸ KDM4E B2RXH2 6/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 4/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 3/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ NCF1 P14598 1/20 0.36
▸ F2R P25116 1/20 0.35
▸ SCN9A Q15858 3/20 0.35
▸ MAOB P27338 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PAX8 Q06710 1/20 0.34
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21865470 0.90 KDM4E (0.40) AOC3KDM4ENPC1RAB9AMAPT
SCHEMBL21864819 0.86 AOC3 (0.47) AOC3KDM4ENPC1RAB9AMAPT
SCHEMBL30228528 0.85 RAB9A (0.41) AOC3KDM4ENPC1RAB9AMAPT
SCHEMBL21864956 0.85 AOC3 (0.56) AOC3MAOB
SCHEMBL21864837 0.84 KDM4E (0.42) KDM4ENPC1RAB9AMAPTALDH1A1
SCHEMBL21865011 0.84 F2 (0.40) KDM4ENPC1RAB9AMAPTALDH1A1
SCHEMBL21865489 0.83 KDM4E (0.43) KDM4ENPC1RAB9AMAPTALDH1A1
SCHEMBL21864962 0.83 KDM4E (0.41) AOC3KDM4ENPC1RAB9AMAPT
SCHEMBL30228559 0.82 ALDH1A1 (0.47) KDM4ENPC1RAB9AMAPTALDH1A1
SCHEMBL28992126 0.82 ALDH1A1 (0.47) KDM4ENPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063854-A1 QUINOLINE-BASED DERIVATIVES AS VAP-1 INHIBITORS 南京明德新药研发有限公司 2020-04-02 — — WO disclosed
Send feedback